1314751-83-1 Usage
Uses
Used in Pharmaceutical Research and Development:
Glycine, N-[(2S)-2-(hydroxyMethyl)-1-oxo-3-phenylpropyl]-, ethyl ester is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique molecular structure allows it to target specific biochemical pathways, making it a valuable building block in drug development.
Used in Organic Synthesis:
In the field of organic chemistry, Glycine, N-[(2S)-2-(hydroxyMethyl)-1-oxo-3-phenylpropyl]-, ethyl ester serves as a versatile reagent for the synthesis of a wide range of organic compounds. Its properties and reactivity enable chemists to create new molecules with potential applications in various industries.
Used in Drug Development:
Glycine, N-[(2S)-2-(hydroxyMethyl)-1-oxo-3-phenylpropyl]-, ethyl ester is used as a potential drug candidate in the development of new therapeutic agents. Its ability to target specific biochemical pathways makes it a promising candidate for the treatment of various diseases and conditions.
Used in the Synthesis of Bioactive Compounds:
In the field of bioactive compound synthesis, Glycine, N-[(2S)-2-(hydroxyMethyl)-1-oxo-3-phenylpropyl]-, ethyl ester is employed as a precursor for the creation of novel bioactive molecules. Its unique structure and reactivity contribute to the development of compounds with potential applications in medicine, agriculture, and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1314751-83-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,7,5 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1314751-83:
(9*1)+(8*3)+(7*1)+(6*4)+(5*7)+(4*5)+(3*1)+(2*8)+(1*3)=141
141 % 10 = 1
So 1314751-83-1 is a valid CAS Registry Number.
1314751-83-1Relevant academic research and scientific papers
IMPROVED PROCESS FOR THE PREPARATION OF [[2(S)-[[4(R)-(3-HYDROXYPHENYL)-3(R),4-DIMETHYL-1-PIPERIDINYL]METHYL]-1-OXO-3-PHENYLPROPYL]AMINO]ACETIC ACID DIHYDRATE
-
, (2017/09/13)
The present invention relates to an improved process for the preparation of [[2(S)-[[4(R)-(3-hydroxyphenyl)-3(R),4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]amino]acetic acid dihydrate, represented by the following structural formula (I).
PROCESS FOR THE PREPARATION OF ALVIMOPAN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF
-
Page/Page column 26, (2012/01/13)
The present invention relates to novel intermediates, ethyl N-[(2S)-2 -benzyl-3- hydroxypropanoyl]glycinate and ethyl N-[(2S)-2-benzyl-3-{[(4-bromophenyl)sulfonyl] oxy}propanoyl]glycinate, and processes for their preparation. The present invention also relates to a process for producing alvimopan or its pharmaceutically acceptable salt or solvate thereof using these novel intermediates.(A).
